Replies to post #380662 on Elite Pharmaceuticals Inc (ELTP)

[NASDAQ2020]

Purdue Patents for Extended-Release OxyContin Nixed in Intas Win

Judge agrees with Intas’ Accord, cancels five Purdue patents
‘Existing monopoly’ fueled abuse-deterrent version’s success
A federal judge voided five patents Purdue Pharma LP alleges are infringed by generic versions of extended-release OxyContin proposed by Intas Pharmaceuticals Ltd.’s Accord unit, finding they cover obvious inventions and shouldn’t have been issued.

https://news.bloomberglaw.com/ip-law/purdue-patents-for-extended-release-oxycontin-nixed-in-intas-win